NDC 51759-202 – Ajovy

Fremanezumab 225 mg/1.5mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC51759-202

Product details

Brand name
Ajovy
Generic name
Fremanezumab-vfrm
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761089
Marketed since
March 29, 2020
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Ajovy →

Package NDC codes (3)

Package NDCDescriptionSince
51759-202-101 CONTAINER in 1 CARTON (51759-202-10) / 1.5 mL in 1 CONTAINERMar 29, 2020
51759-202-11 sample1 CONTAINER in 1 CARTON (51759-202-11) / 1.5 mL in 1 CONTAINERMar 29, 2020
51759-202-223 CONTAINER in 1 CARTON (51759-202-22) / 1.5 mL in 1 CONTAINERAug 31, 2020

Other Ajovy products